StemiRNA Therapeutics — a clinical stage mRNA biopharmaceutical company located in Shanghai, Beijing and Boston — recently announced the appointment of Dr. Jack Hu as CFO.
The global IPO market had an exceptional year in 2021 despite all the uncertainties, breaking records by IPO volume and
Geoff Soon (pictured), Senior District Manager for ASEAN, Snowflake spoke to FutureCFO about the consumption business model, how it would
The 2022 economic outlook is defined by digital resilience and a return to the experience economy, said MasterCard Economics Institute
The year 2021 saw the highest total M&A deal value on record, reaching more than US$5 trillion, said Bain &
To become more sustainable and resilient in the long term, Hong Kong listed companies and public sector organisations will need
While 76% of finance leaders in companies around the world now back the need for globally consistent ESG standards, obstacles
Hong Kong exports will grow by 8% in value in 2022, down from the 25% expansion experienced in 2021, said
CFOs must be aware of cases and risks of digital currencies as 20% of large organisations will use them by
Only one-third (33%) of investors think the quality of ESG reporting they see is good, with under half (40%) trusting
China’s shadow banking assets will continue to decline on regulators’ continued focus on containing systemic risks in the financial sector,
When it comes to global trade, supply chain disruptions could remain high until 2H 2022 amid renewed Covid-19 outbreaks around
